Inventor · disambiguated record
Dmitry Zubov
Also filed as: ZUBOV DMITRY
17 granted patents·16 pending applications·95 citations·filing 2000–2023
92Inventor score
Top patents by PatentIndex Score
33 records- 0194US10300062B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2018·Granted May 28, 2019·11 cites·21 claims
- 0293US9949978B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·42 claims
- 0393US9949977B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2016·Granted Apr 24, 2018·12 cites·19 claims
- 0493US9481672B2Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2013·Granted Nov 1, 2016·18 cites·44 claims
- 0588US8119663B2Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2008·Granted Feb 21, 2012·16 cites·8 claims
- 0684US8273752B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2008·Granted Sep 25, 2012·11 cites·5 claims
- 0775US10722501B2Substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-A]pyridine-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-C][1,2,4]triazol-3-ones, and use thereofBAYER AG·Filed 2017·Granted Jul 28, 2020·2 cites·19 claims
- 0875US9695131B2Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2014·Granted Jul 4, 2017·2 cites·4 claims
- 0974US9751843B2Substituted uracils and use thereofBayer Pharma AG·Filed 2014·Granted Sep 5, 2017·2 cites·10 claims
- 1074US8987248B2Substituted piperidines as Par-1 antagonistsJESKE MARIO·Filed 2010·Granted Mar 24, 2015·1 cites·9 claims
- 1171US12503491B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2023·Granted Dec 23, 2025·0 cites·8 claims
- 1271US6835381B1Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding thereforBAYER AG·Filed 2000·Granted Dec 28, 2004·8 cites·27 claims
- 1365US2020061063A1Bicyclically substituted uracils and the use thereofBayer Pharma AG·Filed 2019·Application pending·0 cites
- 1462US11667675B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 1552US2024010684A1Masp inhibitory compounds and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 1650US2015183773A1Substituted piperidinesBayer Pharma AG·Filed 2015·Application pending·0 cites
- 1748US6808883B1Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probesBAYER AG·Filed 2000·Granted Oct 26, 2004·0 cites·10 claims
- 1848US2017267648A1Substituted uracils as chymase inhibitorsBayer Pharma AG·Filed 2017·Application pending·0 cites
- 1947US9051323B2Substituted imidazopyrimidines and triazolopyrimidinesSIEGEL STEPHAN·Filed 2012·Granted Jun 9, 2015·0 cites·6 claims
- 2047US2011110944A1Anti-alk1 antibodies and uses thereofMORPHOSYS AG·Filed 2009·Application pending·0 cites
- 2146US2016287599A1Substituted 1,2,4-triazine-3,5-diones and the use thereof as chymase inhibitorsBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2245US12398120B2Substituted hydantoinamides as ADAMTS7 antagonistsBAYER AG·Filed 2020·Granted Aug 26, 2025·0 cites·17 claims
- 2345US2012214788A1Heteroaryl-substituted piperidinesHEIMBACH DIRK·Filed 2012·Application pending·0 cites
- 2445US2023027985A1Substituted hydantoinamides as adamts7 antagonistsBAYER AG·Filed 2020·Application pending·0 cites
- 2543US2016237160A1Anti-tweakr antibodies and uses thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 2643US2022412975A1Characterizing modulators of adamts-7 and adamts-12BROAD INST INC·Filed 2020·Application pending·0 cites
- 2742US2007254287A1Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 10 (Dpp10)BAYER HEALTHCARE AG·Filed 2005·Application pending·0 cites
- 2841US2005032094A1Regulatory DNA sequences of the human catalytic telomerase sub-unit gene, diagnostic and therapeutic use thereofBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 2940US2008166357A1Diagnostics and Therapeutics for Diseases Associated with Dipeptidyl-Peptidase 6 (Dpp6)GOLZ STEFAN·Filed 2005·Application pending·0 cites
- 3038US11337973B2Substituted [1,2,4]triazolo[4,3-A]pyrazines as prolyl endopeptidase inhibitorsBAYER AG·Filed 2018·Granted May 24, 2022·0 cites·31 claims
- 3135US2012149694A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 3235US2012129831A1Substituted 3-(1,2,4-Oxadiazol-5-yl)-5-PhenylpiperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
- 3333US2012142690A1Substituted piperidinesHEIMBACH DIRK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dmitry Zubov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →